Dentis sponsors key products in SBS drama 'Dr. X'
Predicted impact: Low
Product sponsorship in a drama; small marketing deal with no revenue figures given.
261200 · KOSDAQ · ₩261200 · 덴티스
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−48.5% from the high
₩2,125Today: ₩2,480 – ₩2,545₩4,895
Returns
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals describe activity, not recommendations. Not financial advice.
Dentis (덴티스, KRX: 261200) is listed on KOSDAQ, in the Medical & precision devices sector. The company was founded in March 2005 and develops, manufactures and sells dental implants as its main product, along with dental LED medical lighting, dental 3D printers and bio products such as synthetic bone graft materials and barrier membranes. Its shares closed at ₩2,520 on Oct 28, 2026, up 0.20% on the day, giving it a market value of ₩40B.
The company was founded in March 2005 and develops, manufactures and sells dental implants as its main product, along with dental LED medical lighting, dental 3D printers and bio products such as synthetic bone graft materials and barrier membranes. Its products are sold in South Korea directly to private clinics, large hospitals and dealers, and overseas through dealers and, in some countries, local subsidiaries. The company listed on the KOSDAQ market in July 2020.
Written by AI from the company's latest annual report.
Predicted impact: Low
Product sponsorship in a drama; small marketing deal with no revenue figures given.
Titles in Korean until English translations are added.
Also known as: Dentis / 덴티스 / 261200 / KRX:261200
Source: KRX statistical information